Looking to list your PhD opportunities? Log in here.
About the Project
To decrease the risk of acute infective exacerbations or flare-ups of their condition, individuals with bronchiectasis and COPD are frequently prescribed long-term oral and inhaled antibiotics. However, it is not clear what effect such antibiotic treatment has on microbial community composition and the development of antibiotic resistance and how this relates to patient outcomes.
As part of an ongoing collaboration between Queens University Belfast and the University of Dundee, we have access to a large number of clinical samples and extensive clinical and biomarker data from patients enrolled in clinical studies and the European Bronchiectasis Registry (EMBARC). In this project, we will determine whether microbiota composition and presence of resistance genes in these samples correlates with previous antibiotic treatment. Metagenomic analysis will be performed to determine the abundance of genes encoding antimicrobial resistance, the 'resistome', within the community of bacteria as a whole, and how it changes in response to treatment. The relationship between development of resistance and an extensive range of clinical outcomes (lung function, quality of life, time to next exacerbation) and measures of inflammation will also be determined.
This project will provide extensive training in, clinical pharmacy, clinical trial methodology, molecular microbiology, inflammatory biomarker measurement and statistical analysis as part of an inter-disciplinary and internationally renowned research team. This study will use rich clinical metadata and molecular resistance markers to explore prognostic markers that have potential to drive improvements in clinical care of people with bronchiectasis and COPD.
Home applicants must meet the following academic criteria:
1st or 2.1 honours degree in a relevant subject. Relevant subjects include Pharmacy, Pharmaceutical Sciences, Biochemistry, Biological/Biomedical Sciences, Chemistry, Engineering, or a closely related discipline.
International applicants must meet the following academic criteria:
IELTS (or equivalent) of 7.0, a 2.1 honours degree (or equivalent) and a master’s degree in a relevant subject.
Applicants should apply through the University's Direct Application Portal: https://dap.qub.ac.uk/portal/user/u_login.php
Funding Notes
Email Now
Why not add a message here
The information you submit to Queen’s University Belfast will only be used by them or their data partners to deal with your enquiry, according to their privacy notice. For more information on how we use and store your data, please read our privacy statement.

Search suggestions
Based on your current searches we recommend the following search filters.
Check out our other PhDs in Belfast, United Kingdom
Check out our other PhDs in United Kingdom
Start a New search with our database of over 4,000 PhDs

PhD suggestions
Based on your current search criteria we thought you might be interested in these.
Antimicrobial drug development: Synthesis, characterisation, and evaluation of novel antimicrobial agents to combat antimicrobial resistance.
University of Wolverhampton
Development of a physiologically relevant platform to inform clinical practice and limit antimicrobial resistance in orthopaedic implants
University of Birmingham
The role of ethnicity on the anti-inflammatory effects of lifestyle activity and pulmonary rehabilitation in patients living with Chronic Obstructive Pulmonary Disease (COPD)
University of Leicester